Dominik K Koelmel

Title: Dominik K. Koelmel: Inventor in Therapeutics

Introduction

Dominik K. Koelmel is an inventor associated with Ann Arbor, Michigan, and Odyssey Therapeutics, Inc. His patent work concerns potential treatments targeting RIPK2, a protein involved in inflammatory signaling.

Latest Patents

Koelmel is named on one patent: “Inhibitors of RIPK2 and Medical Uses Thereof.” The disclosure describes RIPK2 inhibitors, pharmaceutical compositions containing them, and methods of treating conditions including inflammatory and autoimmune diseases, granulomatous disease, neurodegenerative disease, and cancer. The patent describes potential applications and does not, by itself, establish that a treatment is approved or clinically effective. Koelmel’s reported portfolio includes 1 patent.

Career Highlights

Koelmel’s listed work connects him with Odyssey Therapeutics, Inc., a biotechnology company, and with research into therapeutic compounds. The available information identifies his patent contribution but does not provide further details about his role or career history.

Collaborations

The supplied information lists Chad Vanhuis and Shifeng Pan as Koelmel’s coworkers. Their names also appear in connection with the collaborative research described in the patent.

Conclusion

Dominik K. Koelmel’s identified invention focuses on RIPK2 inhibitors and their potential medical uses, reflecting a patent contribution in therapeutic research.